Announcements Trials
Browse Landscape

Phase

Phase 2 1

Status

Withdrawn 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Other 1

Conditions

Pain, Intractable 1Obesity 1Neoplasms 1Nausea 1Dyspnea 1Delirium 1Death 1

Interventions

Surveys and Questionnaires 5Oxygen 2Dexamethasone 2Calcium Dobesilate 2Acupuncture Therapy 2dexamethasone acetate 1dexamethasone 21-phosphate 1auricularum 1Tiotropium Bromide 1Sugars 1Standard of Care 1Respiratory Therapy 1Rehabilitation 1Psychiatric Rehabilitation 1Midazolam 1Losartan 1Lisinopril 1Hypnosis 1Hematologic Tests 1Furosemide 1Fentanyl 1Exercise 1Educational Status 1Echocardiography 1Early Intervention, Educational 1Dexmedetomidine 1Caregivers 1Buspirone 1Behavior Therapy 1Aromatherapy 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Dyspnea × Dexmedetomidine × Other × Clear all
NCT01687751 2015-05-25

Pilot Study Comparing Treatment With Dexmedetomidine to Midazolam for Symptom Control in Advanced Cancer Patients

Fraser Health

Phase 2 Withdrawn
Other

Death, Delirium, Dyspnea, Nausea, Neoplasms, Pain, Intractable

Data powered by HemOnc (CC BY 4.0) Colophon âš¡